Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Oric Pharmaceuticals, Inc. - Common Stock (NQ: ORIC )

11.23 +0.48 (+4.47%)
Streaming Delayed Price Updated: 10:49 AM EST, Feb 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Oric Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023
Via Benzinga
ORIC Pharmaceuticals Announces Multiple Presentations at the 2023 American Association for Cancer Research (AACR) Annual Meeting
From ORIC Pharmaceuticals
Via GlobeNewswire
ORIC Pharmaceuticals to Participate in the Oppenheimer 33rd Annual Healthcare Conference
From ORIC Pharmaceuticals
Via GlobeNewswire
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From ORIC Pharmaceuticals
Via GlobeNewswire
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
From ORIC Pharmaceuticals
Via GlobeNewswire
7 Top Short-Squeeze Candidates to Watch in February
For those that want to zig while others zag, these heavily targeted stocks represent the top short-squeeze candidates to watch this month. 
Via InvestorPlace
ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones
From ORIC Pharmaceuticals
Via GlobeNewswire
ORIC Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
From ORIC Pharmaceuticals
Via GlobeNewswire
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
US Stocks Open Lower; Dow Falls Over 100 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping over 100 points on Friday. 
Via Benzinga
Dow Dips 600 Points; AMC Entertainment Shares Plunge
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 600 points on Thursday. 
Via Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Nasdaq Down Over 3%; IsoPlexis Shares Spike Higher
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 600 points on Thursday. 
Via Benzinga
CENN Stock Alert: Cenntro Electric Receives EPA Certification
Cenntro Electric (CENN) stock is on the move Thursday as investors react to the EPA granting a Certificate of Conformity to the company. 
Via InvestorPlace
Dow Tumbles 300 Points; US Economy Expands 3.2% In Q3
U.S. stocks traded lower this morning, with the Dow Jones dropping over 300 points on Thursday. 
Via Benzinga
ORIC Pharmaceuticals (ORIC) Stock Rockets 58% on Pfizer Deal
ORIC Pharmaceuticals (ORIC) stock is rocketing higher after the company revealed a collaboration agreement with Pfizer (PFE). 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
ORIC Pharmaceuticals Shares Move Higher After Equity Infusion, Clinical Collaboration From Pfizer
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on for Thursday! 
Via InvestorPlace
Why ORIC Pharmaceuticals Shares Are Trading Higher By Around 46%; Here Are 27 Stocks Moving Premarket
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares rose 77.7% to $0.0906 in pre-market trading. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy. 
Via Benzinga
ORIC Pharmaceuticals Announces Clinical Development Collaboration with Pfizer for ORIC-533 in Multiple Myeloma and Concurrent $25 Million Equity Investment by Pfizer
From ORIC Pharmaceuticals
Via GlobeNewswire
ORIC Pharmaceuticals Presents Preclinical Data Demonstrating ORIC-533 as a Potential Best-in-Class CD73 Inhibitor at the 64th American Society of Hematology (ASH) Annual Meeting
From ORIC Pharmaceuticals
Via GlobeNewswire
ORIC Pharmaceuticals to Present at the Jefferies London Healthcare Conference
From ORIC Pharmaceuticals
Via GlobeNewswire
ORIC Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Update
From ORIC Pharmaceuticals
Via GlobeNewswire
ORIC Pharmaceuticals to Present Preclinical Data on CD73 Inhibitor Program in Multiple Myeloma at the 64th American Society of Hematology (ASH) Annual Meeting
From ORIC Pharmaceuticals
Via GlobeNewswire
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From ORIC Pharmaceuticals
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 236 companies set new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
  
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.